Tag: REN

Drug-free migraine treatment gains additional US FDA clearance for preventative use

Theranica has announced that its drug-free Nerivio prescription wearable recently received US Food and Drug Administration (FDA) clearance as a dual-use acute and preventive...

Nerivio neuromodulation device achieves positive results in placebo-controlled migraine trial

Theranica Bio-electronics has announced positive top-line results in its double-blind, randomised, placebo-controlled, multicentre, pivotal clinical trial in the USA. This trial evaluated the efficacy...

Nerivio demonstrates comparable effectiveness to standard-care medications in chronic migraine

Theranica has announced the publication of a new study comparing the effectiveness of Remote electrical neuromodulation (REN) to that of standard-care medications for the acute treatment...

Study shows positive impact of new in-app feature on Nerivio REN...

A new peer-reviewed study published in Pain Medicine, examining the use of Nerivio’s (Theranica) guided imagery, education and relaxation (GIER) in-app optional behavioural intervention...

Large real-world analysis deems Nerivio safe and effective in migraine treatment

Theranica has announced a new peer-reviewed study analysing the efficacy, safety and sustainability of remote electrical neuromodulation (REN) as a standalone, and medication-adjunct, treatment...

Study indicates safety and efficacy of remote electrical neuromodulation in chronic...

Theranica has announced the publication of a new, peer-reviewed article in Pain Reports detailing a study assessing its novel, drug-free treatment option for chronic...